amaxa eNews #1 amaxa biosystems
  Issue:
Article:
ContactLegal
Dear Scientist,
We would like to introduce to you the first issue of our new quarterly amaxa eNews. You will only receive future issues of it if you specifically subscribe to this service.
Each amaxa eNews issue features a “Hot Topic”, which discusses one specific application or cell type in detail and highlights new transfection technologies and the opportunities they offer.

If you like amaxa eNews make sure to subscribe to receive future issues or recommend it to your friends and colleagues.

Enjoy reading!
Your amaxa team
Hot Topic: 96-well Transfection

96-well Shuttle
With amaxa's new Nucleofector 96-well Shuttle System high throughput transfection of virtually any cell type is no longer out of reach. The 96-well Shuttle System is the ideal tool for cDNA and RNAi library screening in cell lines as well as primary cells…

       Product Information


The Nucleofector 96-well Shuttle is an add-on to the manual Nucleofector II Device, offering consistent and reproducible results with up to 95% transfection efficiency and 90% viability…

       Application Note


First results on high throughput transfection of primary rat neurons for future siRNA screening experiments …

By Zeitelhofer et al., Dept. of Neuronal Cell Biology, Center for Brain Research, Medical University of Vienna, Austria

       Webcast


amaxa's CEO, Rainer Christine is pleased to present amaxa's new Nucleofector 96-well Shuttle System, including brand new data generated with the technology. Subsequently you can discuss your questions with him on June 13, 2006 at 9 am (PDT) - 12 pm (EDT) - 6 pm (CEST).

       FAQ

Interested in learning more about high throughput nucleofection? Then browse through our first set of Frequently Asked Questions and get to know our new Nucleofector 96-well Shuttle System in more detail.



News

Meet us at AAI 2006
and win an iPod Nano.

May 12 - 16, 2006
Boston, USA
Booth # 217

Learn more about the
Nucleofector Technology
during the talk:

"On viral cytopathicity and cytokine regulation of NK cell receptors"
by Steven J. Burgess, Li Yu and Michael Lenardo
at amaxa's Exhibitor Workshop
Saturday, May 13, 2006
at 6-7 PM (Room 202)

Read more and register for participation.

Subscribe here

...to receive future issues of amaxa eNews.
Invite a friend

Recommend amaxa's eNews to a friend or colleague.

Meetings & Shows

View meetings at which amaxa will be present between May and July 2006.
amaxa's Website

Please visit amaxa's Website.

Preview

amaxa eNews #2
coming in July 2006

Featuring:
Somatic Stem Cells and Nucleofection

You have received this e-mail in the genuine belief that its contents would be of interest to you or because you have requested information from amaxa AG before.

If you do not wish to receive any more e-mails from amaxa please click here to unsubscribe.

The Nucleofector Technology, comprising Nucleofection Process, Nucleofector Device, Nucleofector Solutions, Nucleofector 96-well Shuttle System and 96-well Nucleocuvette plates and modules are covered by patent and/or patent pending rights owned by amaxa.

amaxa, gene transfer begins here, maxFP, maxGFP, Nucleocuvette, nucleofection, Nucleofector and 96-well Shuttle are trademarks of amaxa AG.